The epidemiology of preventable adverse drug events: A review of the literature

Wiener Klinische Wochenschrift

Volumn 115, Issue 12, 2003, Pages 407-415

  Von Laue, Nicoletta C ^a   Schwappach, David L B ^a   Koeck, Christian M ^a,b  

^a UNIVERSITY OF WITTEN HERDECKE   (Germany)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Adverse drug events; Epidemiology; Literature review; Medical injury; Medication errors

Indexed keywords

ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; ANTIHYPERTENSIVE AGENT; ANTINEOPLASTIC AGENT; CARDIOVASCULAR AGENT;

ALLERGY; COMPUTER SYSTEM; COST; DRUG SURVEILLANCE PROGRAM; HEALTH CARE PERSONNEL; HEALTH CARE SYSTEM; HOSPITAL; HUMAN; INCIDENCE; PHARMACIST; PRESCRIPTION; RASH; REVIEW; RISK ASSESSMENT; RISK FACTOR; SAFETY;

EID: 0038026021     PISSN: 00435325     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03040432     Document Type: Review

References (45)

1. Kohn LT, Corrigan J, Donaldson MS (2000) To err is human: building a safer health system. National Academy Press, Washington, D.C.
2. Phillips DP, Christenfeld N, Glynn LM (1998) Increase in US medication-error deaths between 1983 and 1993. Lancet 351: 643-644
3. National Wholesale Druggists' Association. Reston, VA: 1998
4. Manasse HR Jr (1989) Medication use in an imperfect world: drug misadventuring as an issue of public policy, Part 2. Am J Hosp Pharm 46: 1141-1152
5. von Laue N, Schwappach DLB, Koeck CM (2003) The epidemiology of medical errors: a review of the literature. Wien Klin Wochenschr 115: 318-325
6. Brennan TA, Leape LL, Laird NM, Hebert L, Localio AR, Lawthers AG, et al (1991) Incidence of adverse events and negligence in hospitalized patients. Results of the Harvard Medical Practice Study I. N Engl J Med 324: 370-376
7. Reason JT (1990) Human error. Cambridge University Press, Cambridge New York
8. Classen DC, Pestotnik SL, Evans RS, Lloyd JF, Burke JP (1997) Adverse drug events in hospitalized patients. Excess length of stay, extra costs, and attributable mortality. JAMA 277: 301-306
9. Roughead EE, Gilbert AL, Primrose JG, Sansom LN (1998) Drug-related hospital admissions: a review of Australian studies published 1988-1996. Med J Aust 168: 405-408
10. Hayward RA, Hofer TP (2001) Estimating hospital deaths due to medical errors: preventability is in the eye of the reviewer. JAMA 286: 415-420
11. Leape L, Meisel S (2000) Reducing medical errors: lessons from collaborative efforts to prevent errors in prescribing. 5th Forum of quality improvement in health care, Amsterdam
12. Cullen DJ, Bates DW, Small SD, Cooper JB, Nemeskal AR, Leape LL (1995) The incident reporting system does not detect adverse drug events: a problem for quality improvement. Jt Comm J Qual Improv 21: 541-548
13. Thomas EJ, Studdert DM, Burstin HR, Orav EJ, Zeena T, Williams EJ, et al (2000) Incidence and types of adverse events and negligent care in Utah and Colorado. Med Care 38: 261-271
14. Leape LL, Brennan TA, Laird N, Lawthers AG, Localio AR, Barnes BA, et al (1991) The nature of adverse events in hospitalized patients. Results of the Harvard Medical Practice Study II. N Engl J Med 324: 377-384
15. Leape LL, Lawthers AG, Brennan TA, Johnson WG (1993) Preventing medical injury. QRB Qual Rev Bull 19: 144-149
16. Wilson RM, Runciman WB, Gibberd RW, Harrison BT, Newby L, Hamilton JD (1995) The Quality in Australian Health Care Study. Med J Aust 163: 458-471
17. Classen DC, Pestotnik SL, Evans RS, Burke JP (1991) Computerized surveillance of adverse drug events in hospital patients. JAMA 266: 2847-2851
18. Bates DW, Leape LL, Petrycki S (1993) Incidence and preventability of adverse drug events in hospitalized adults. J Gen Intern Med 8: 289-294
19. Bates DW, Cullen DJ, Laird N, Petersen LA, Small SD, Servi D, et al (1995) Incidence of adverse drug events and potential adverse drug events. Implications for prevention. ADE Prevention Study Group. JAMA 274: 29-34
20. Honigman B, Lee J, Rothschild J, Light P, Pulling RM, Yu T, et al (2001) Using computerized data to identify adverse drug events in outpatients. J Am Med Inform Assoc 8: 254-266
21. Einarson TR (1993) Drug-related hospital admissions. Ann Pharmacother 27: 832-840
22. Schneitman-McIntire O, Farnen TA, Gordon N, Chan J, Toy WA (1996) Medication misadventures resulting in emergency department visits at and HMO medical center. Am J Health Syst Pharm 53: 1416-1422
23. Hallas J, Haghfelt T, Gram LF, Grodum E, Damsbo N (1990) Drug related admissions to a cardiology department; frequency and avoidability. J Intern Med 228: 379-384
24. Bates DW, Boyle DL, Vander Vliet MB, Schneider J, Leape L (1995) Relationship between medication errors and adverse drug events. J Gen Intern Med 10: 199-205
25. Lesar TS, Briceland LL, Delcoure K, Parmalee JC, Masta Gornic V, Pohl H (1990) Medication prescribing errors in a teaching hospital. JAMA 263: 2329-2334
26. Lesar TS, Lomaestro BM, Pohl H (1997) Medication-prescribing errors in a teaching hospital. A 9-year experience. Arch Intern Med 157: 1569-1576
27. Conroy S, Choonara I, Impicciatore P, Mohn A, Arnell H, Rane A, et al (2000) Survey of unlicensed and off label drug use in paediatric wards in European countries. European Network for Drug Investigation in Children. BMJ 320: 79-82
28. Folli HL, Poole RL, Benitz WE, Russo JC (1987) Medication error prevention by clinical pharmacists in two children's hospitals. Pediatrics 79: 718-722
29. Kaushal R, Bates DW, Landrigan C, McKenna KJ, Clapp MD, Federico F, et al (2001) Medication errors and adverse drug events in pediatric inpatients. JAMA 285: 2114-2120
30. Thomas EJ, Brennan TA (2000) Incidence and types of preventable adverse events in elderly patients: population based review of medical records, BMJ 320: 741-744
31. Bates DW, Miller EB, Cullen DJ, Burdick L, Williams L, Laird N, et al (1999) Patient risk factors for adverse drug events in hospitalized patients. ADE Prevention Study Group [see comments]. Arch Intern Med 159: 2553-2560
32. Cullen DJ, Sweitzer BJ, Bates DW, Burdick E, Edmondson A, Leape LL (1997) Preventable adverse drug events in hospitalized patients: a comparative study of intensive care and general care units. Crit Care Med 25: 1289-1297
33. Andrews LB, Stocking C, Krizek T, Gottlieb L, Krizek C, Vargish T, et al (1997) An alternative strategy for studying adverse events in medical care. Lancet 349: 309-313
34. Bates DW, Spell N, Cullen DJ, Burdick E, Laird N, Petersen LA, et al (1997) The costs of adverse drug events in hospitalized patients. Adverse Drug Events Prevention Study Group. JAMA 277: 307-311
35. Johnson JA, Bootman JL (1995) Drug-related morbidity and mortality. A cost-of-illness model. Arch Intern Med 155: 1949-1956
36. Ernst FR, Grizzle AJ (2001) Drug-related morbidity and mortality: updating the cost-of-illness model. J Am Pharm Assoc (Wash) 41: 192-199
37. Raschke RA, Gollihare B, Wunderlich TA, Guidry JR, Leibowitz AI, Peirce JC, et al (1998) A computer alert system to prevent injury from adverse drug events: development and evaluation in a community teaching hospital. JAMA 280: 1317-1320
38. Evans RS, Pestotnik SL, Classen DC, Horn SD, Bass SB, Burke JP (1994) Preventing adverse drug events in hospitalized patients. Ann Pharmacother 28: 523-527
39. Bates DW, Leape LL, Cullen DJ, Laird N, Petersen LA, Teich JM, et al (1998) Effect of computerized physician order entry and a team intervention on prevention of serious medication errors. JAMA 280: 1311-1316
40. Blum KV, Abel SR, Urbanski CJ, Pierce JM (1988) Medication error prevention by pharmacists. Am J Hosp Pharm 45: 1902-1903
41. Leape LL, Cullen DJ, Clapp MD, Burdick E, Demonaco HJ, Erickson JI, et al (1999) Pharmacist participation on physician rounds and adverse drug events in the intensive care unit. JAMA 282: 267-270
42. Nolan TW (2000) System changes to improve patient safety. BMJ 320: 771-773
43. Leape LL, Bates DW, Cullen DJ, Cooper J, Demonaco HJ, Gallivan T, et al (1995) Systems analysis of adverse drug events. ADE Prevention Study Group. JAMA 274: 35-43
44. Langley GJ, Nolan KM, Nolan TW (1992) The foundation of improvement. API Publishing, Silver Spring
45. Leape LL, Kabcenell AI, Gandhi TK, Carver P, Nolan TW, Berwick DM (2000) Reducing adverse drug events: lessons from a breakthrough series collaborative. Jt Comm J Qual Improv 26: 321-331